Previous 10 | Next 10 |
JACKSON CENTER, PA / ACCESSWIRE / November 9, 2020 / Halberd Corp. (OTC PINK: HALB ) reported the filing of a Covid-19 provisional patent on an enhanced nasal spray. The application, "Nasal Spray to Prevent the Transmission of Covid-19," discloses a combination of proprietary Covid-19 Spike ...
JACKSON CENTER, PA / ACCESSWIRE / November 5, 2020 / Halberd Corporation (OTC PINK: HALB ) reports its research team developed a second monoclonal antibody against Covid-19 SARS 2 disease antigens paving the way for development of a potentially more effective nasal spray. Additionally, Halbe...
In Case You Missed It - Mr. Hartman discusses recent accomplishments and new opportunities. JACKSON CENTER, PA / ACCESSWIRE / November 2, 2020 / Halberd Corporation (OTC PINK: HALB ) Chairman, President and CEO, William A. Hartman, was interviewed recently by host, Donald Baillargeo...
HOLLYWOOD, CA / ACCESSWIRE / October 30, 2020 / Covid-19 antibodies, functional nutrition, CBD, gold market, Presidential endorsement; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, ( http:...
JACKSON CENTER, PA / ACCESSWIRE / October 29, 2020 / Halberd Corporation (OTC PINK: HALB ) today provided insight concerning its strategic plans beyond developing unique antibodies which form the basis of their current all-out efforts to generate products and processes to prevent, diagnose a...
Phoenix, Arizona--(Newsfile Corp. - October 22, 2020) - The Stock Day Podcast welcomed Halberd Corporation (OTC Pink: HALB) ("the Company"), a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. CEO of the Company, Bill Hartman, joined S...
JACKSON CENTER, PA / ACCESSWIRE / October 19, 2020 / Halberd Corporation (OTC PINK: HALB ) today announced the creation of a new class of anti-Spike protein monoclonal antibodies against Covid-19. The discovery is the result of Halberd's research in conjunction with Arizona State University'...
JACKSON CENTER, PA / ACCESSWIRE / October 13, 2020 / Halberd Corporation (OTC PINK: HALB ) reported that Arizona State University researchers, utilizing the intellectual property of Halberd Corporation, have successfully generated an anti-Spike protein monoclonal antibody against Covid-19. T...
Greetings From the CEO and Staff at Halberd Corporation! (OTC PINK: HALB ) JACKSON CENTER, PA / ACCESSWIRE / October 8, 2020 / This initial CEO Letter reflects a summary of major accomplishments since I began my tenure at Halberd Corporation. Going forward, I intend to provide update le...
JACKSON CENTER, PA / ACCESSWIRE / October 1, 2020 / Halberd Corporation (OTC PINK: HALB ) announced they have obtained world-wide license to a provisional patent application covering a nasal spray to be used as a prevention measure against coronavirus. The provisional patent, " Nasal Spray T...
News, Short Squeeze, Breakout and More Instantly...
Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues ...
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd Corporation's (OTC PINK:HALB) two active programs for the treatment and mitigation of the negative ...
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited participants but is currently expected to...